- Position Statements
- Press Release
The HPCUS Friends of the Pharmacopoeia Program
By Dr. William Shevin, President, HPCUS Due to challenges in general for homeopathy and specifically for the Homeopathic Pharmacopoeia Convention of the United States (HPCUS),...
What’s In a Name?
By Al Lorman, AAHP Counsel FDA's issuance of its new guidance on homeopath drugs in December, 2022 has caused concern in some quarters because of...
A Retrospective Policy Analysis of FDA’s CPG 400.400
The origins of FDA's CPG 400.400 go back to a series of meetings between industry and Agency enforcement personnel in the 1980s. The resulting CPG...